| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| D881198 | 1809427-19-7 | DT-061 , ≥99% DT-061 , ≥99% |
C25H23F3N2O5S | |
| D873080 | 1809784-29-9 | DTP3, 99% DTP3, 99% |
C26H35N7O5 | |
| D795038 | 1809784-29-9 | DTP3, 10mM in DMSO DTP3, 10mM in DMSO |
C26H35N7O5 | |
| D878274 | 59943-31-6 | DU717 , 98% DU717 , 98% |
C12H15ClN4O2S | |
| D876197 | 949095-98-1 | Duloxetine metabolite Para-Naphthol Duloxetine, 98% Duloxetine metabolite Para-Naphthol Duloxetine, 98% |
C18H19NOS | |
| D881926 | 157922-77-5 | Duocarmycin TM , ≥98% Duocarmycin TM , ≥98% |
C25H23ClN2O5 | |
| D878159 | 62030-88-0 | Duoperone , 98% Duoperone , 98% |
C28H26F4N2OS | |
| D876100 | 96800-41-8 | DuP 105 , 98% DuP 105 , 98% |
C13H16N2O4S | |
| D882491 | 1428935-60-7 | Durvalumab, ≥99% Durvalumab, ≥99% |
||
| D877031 | 852329-66-9 | Dutogliptin, 98% Dutogliptin, 98% |
C10H20BN3O3 | |
| D855381 | 1201438-56-3 | Duvelisib (IPI-145, INK1197), 99% Duvelisib (IPI-145, INK1197), 99% |
C22H17ClN6O | |
| D795537 | 1201438-56-3 | Duvelisib (IPI-145, INK1197), 10mM in DMSO Duvelisib (IPI-145, INK1197), 10mM in DMSO |
C22H17ClN6O | |
| D883553 | 1261590-48-0 | Duvelisib R enantiomer, ≥98% Duvelisib R enantiomer, ≥98% |
C22H17ClN6O | |
| D878836 | 491577-61-8 | DW-1350 , 98% DW-1350 , 98% |
C25H31N3O3S | |
| Z937956 | 623574-00-5 | DW-224a, ≥98% Zabofloxacin hydrochloride, ≥98% |
C19H21ClFN5O4 | |
| D881869 | 1599440-33-1 | Dxd, ≥98% Dxd, ≥98% |
C26H24FN3O6 | |
| D766845 | 152-62-5 | Dydrogesterone, 10mM in DMSO Dydrogesterone, 10mM in DMSO |
C21H28O2 | |
| D882070 | 152-62-5 | Dydrogesterone , 99% Dydrogesterone , 99% |
C21H28O2 | |
| D880851 | 195199-04-3 | Dye 937 , 98% Dye 937 , 98% |
C32H37IN4S | |
| D872529 | 1256493-34-1 | Dyngo-4a, 96% Dyngo-4a, 96% |
C18H14N2O5 |